nodes	percent_of_prediction	percent_of_DWPC	metapath
Gallamine Triethiodide—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.00106	0.00134	CcSEcCtD
Gallamine Triethiodide—Cough—Gliclazide—type 2 diabetes mellitus	0.00106	0.00134	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.00106	0.00134	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.00106	0.00134	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.00106	0.00133	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Ramipril—type 2 diabetes mellitus	0.00106	0.00133	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.00105	0.00132	CcSEcCtD
Gallamine Triethiodide—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.00104	0.00132	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Losartan—type 2 diabetes mellitus	0.00104	0.00131	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Gliclazide—type 2 diabetes mellitus	0.00104	0.00131	CcSEcCtD
Gallamine Triethiodide—Chest pain—Gliclazide—type 2 diabetes mellitus	0.00104	0.00131	CcSEcCtD
Gallamine Triethiodide—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00104	0.00131	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00103	0.00131	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Losartan—type 2 diabetes mellitus	0.00103	0.0013	CcSEcCtD
Gallamine Triethiodide—Nausea—Repaglinide—type 2 diabetes mellitus	0.00103	0.0013	CcSEcCtD
Gallamine Triethiodide—Asthenia—Glipizide—type 2 diabetes mellitus	0.00103	0.0013	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.00103	0.0013	CcSEcCtD
Gallamine Triethiodide—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00103	0.0013	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	0.00102	0.00129	CcSEcCtD
Gallamine Triethiodide—Angioedema—Valsartan—type 2 diabetes mellitus	0.00102	0.00129	CcSEcCtD
Gallamine Triethiodide—Pruritus—Glipizide—type 2 diabetes mellitus	0.00102	0.00128	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.00101	0.00128	CcSEcCtD
Gallamine Triethiodide—Angioedema—Orlistat—type 2 diabetes mellitus	0.00101	0.00127	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.00101	0.00127	CcSEcCtD
Gallamine Triethiodide—Confusional state—Gliclazide—type 2 diabetes mellitus	0.001	0.00126	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Metformin—type 2 diabetes mellitus	0.000998	0.00126	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000998	0.00126	CcSEcCtD
Gallamine Triethiodide—Malaise—Orlistat—type 2 diabetes mellitus	0.000997	0.00126	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000994	0.00125	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000989	0.00125	CcSEcCtD
Gallamine Triethiodide—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000988	0.00125	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000985	0.00124	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000984	0.00124	CcSEcCtD
Gallamine Triethiodide—Cough—Valsartan—type 2 diabetes mellitus	0.000976	0.00123	CcSEcCtD
Gallamine Triethiodide—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000976	0.00123	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000973	0.00123	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.00097	0.00122	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000965	0.00122	CcSEcCtD
Gallamine Triethiodide—Cough—Orlistat—type 2 diabetes mellitus	0.000965	0.00122	CcSEcCtD
Gallamine Triethiodide—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000963	0.00121	CcSEcCtD
Gallamine Triethiodide—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000962	0.00121	CcSEcCtD
Gallamine Triethiodide—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.00096	0.00121	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000957	0.00121	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000957	0.00121	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000955	0.00121	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000952	0.0012	CcSEcCtD
Gallamine Triethiodide—Chest pain—Valsartan—type 2 diabetes mellitus	0.000952	0.0012	CcSEcCtD
Gallamine Triethiodide—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000949	0.0012	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000946	0.00119	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000942	0.00119	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.000941	0.00119	CcSEcCtD
Gallamine Triethiodide—Chest pain—Orlistat—type 2 diabetes mellitus	0.000941	0.00119	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000935	0.00118	CcSEcCtD
Gallamine Triethiodide—Malaise—Metformin—type 2 diabetes mellitus	0.000919	0.00116	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000918	0.00116	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000915	0.00115	CcSEcCtD
Gallamine Triethiodide—Vomiting—Glipizide—type 2 diabetes mellitus	0.000914	0.00115	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000912	0.00115	CcSEcCtD
Gallamine Triethiodide—Rash—Glipizide—type 2 diabetes mellitus	0.000907	0.00114	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000906	0.00114	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000905	0.00114	CcSEcCtD
Gallamine Triethiodide—Headache—Glipizide—type 2 diabetes mellitus	0.000901	0.00114	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000894	0.00113	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000892	0.00113	CcSEcCtD
Gallamine Triethiodide—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000888	0.00112	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000887	0.00112	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000886	0.00112	CcSEcCtD
Gallamine Triethiodide—Urticaria—Glyburide—type 2 diabetes mellitus	0.000879	0.00111	CcSEcCtD
Gallamine Triethiodide—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000878	0.00111	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000876	0.00111	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000875	0.0011	CcSEcCtD
Gallamine Triethiodide—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000868	0.0011	CcSEcCtD
Gallamine Triethiodide—Chest pain—Metformin—type 2 diabetes mellitus	0.000867	0.00109	CcSEcCtD
Gallamine Triethiodide—Malaise—Irbesartan—type 2 diabetes mellitus	0.000867	0.00109	CcSEcCtD
Gallamine Triethiodide—Headache—Pioglitazone—type 2 diabetes mellitus	0.000863	0.00109	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000861	0.00109	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.00086	0.00109	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000858	0.00108	CcSEcCtD
Gallamine Triethiodide—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000857	0.00108	CcSEcCtD
Gallamine Triethiodide—Nausea—Glipizide—type 2 diabetes mellitus	0.000854	0.00108	CcSEcCtD
Gallamine Triethiodide—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000853	0.00108	CcSEcCtD
Gallamine Triethiodide—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00085	0.00107	CcSEcCtD
Gallamine Triethiodide—Pain—Gliclazide—type 2 diabetes mellitus	0.00085	0.00107	CcSEcCtD
Gallamine Triethiodide—Rash—Glimepiride—type 2 diabetes mellitus	0.000846	0.00107	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000845	0.00107	CcSEcCtD
Gallamine Triethiodide—Rash—Sitagliptin—type 2 diabetes mellitus	0.000843	0.00106	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000843	0.00106	CcSEcCtD
Gallamine Triethiodide—Headache—Glimepiride—type 2 diabetes mellitus	0.000841	0.00106	CcSEcCtD
Gallamine Triethiodide—Cough—Irbesartan—type 2 diabetes mellitus	0.000839	0.00106	CcSEcCtD
Gallamine Triethiodide—Headache—Sitagliptin—type 2 diabetes mellitus	0.000838	0.00106	CcSEcCtD
Gallamine Triethiodide—Anaemia—Losartan—type 2 diabetes mellitus	0.000836	0.00106	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000832	0.00105	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000828	0.00105	CcSEcCtD
Gallamine Triethiodide—Angioedema—Losartan—type 2 diabetes mellitus	0.000827	0.00104	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000822	0.00104	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.00082	0.00103	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000819	0.00103	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000818	0.00103	CcSEcCtD
Gallamine Triethiodide—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000818	0.00103	CcSEcCtD
Gallamine Triethiodide—Malaise—Losartan—type 2 diabetes mellitus	0.000816	0.00103	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000815	0.00103	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000814	0.00103	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000813	0.00103	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.00081	0.00102	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Losartan—type 2 diabetes mellitus	0.00081	0.00102	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Metformin—type 2 diabetes mellitus	0.000808	0.00102	CcSEcCtD
Gallamine Triethiodide—Nausea—Glimepiride—type 2 diabetes mellitus	0.000797	0.00101	CcSEcCtD
Gallamine Triethiodide—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000794	0.001	CcSEcCtD
Gallamine Triethiodide—Asthenia—Glyburide—type 2 diabetes mellitus	0.000794	0.001	CcSEcCtD
Gallamine Triethiodide—Cough—Losartan—type 2 diabetes mellitus	0.000789	0.000996	CcSEcCtD
Gallamine Triethiodide—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000789	0.000996	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000788	0.000995	CcSEcCtD
Gallamine Triethiodide—Fatigue—Valsartan—type 2 diabetes mellitus	0.000787	0.000993	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000785	0.000991	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000785	0.000991	CcSEcCtD
Gallamine Triethiodide—Pruritus—Glyburide—type 2 diabetes mellitus	0.000783	0.000988	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000779	0.000983	CcSEcCtD
Gallamine Triethiodide—Fatigue—Orlistat—type 2 diabetes mellitus	0.000778	0.000981	CcSEcCtD
Gallamine Triethiodide—Pain—Orlistat—type 2 diabetes mellitus	0.000771	0.000973	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Losartan—type 2 diabetes mellitus	0.00077	0.000972	CcSEcCtD
Gallamine Triethiodide—Chest pain—Losartan—type 2 diabetes mellitus	0.00077	0.000972	CcSEcCtD
Gallamine Triethiodide—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00077	0.000971	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000768	0.000969	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000766	0.000966	CcSEcCtD
Gallamine Triethiodide—Rash—Bromocriptine—type 2 diabetes mellitus	0.000763	0.000963	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000763	0.000962	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000762	0.000962	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.00076	0.000959	CcSEcCtD
Gallamine Triethiodide—Headache—Bromocriptine—type 2 diabetes mellitus	0.000758	0.000957	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000757	0.000956	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000757	0.000955	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000746	0.000942	CcSEcCtD
Gallamine Triethiodide—Confusional state—Losartan—type 2 diabetes mellitus	0.000744	0.000939	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000743	0.000938	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000732	0.000924	CcSEcCtD
Gallamine Triethiodide—Urticaria—Valsartan—type 2 diabetes mellitus	0.000725	0.000915	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000723	0.000912	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000722	0.000911	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Losartan—type 2 diabetes mellitus	0.000721	0.000909	CcSEcCtD
Gallamine Triethiodide—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000719	0.000907	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000718	0.000906	CcSEcCtD
Gallamine Triethiodide—Fatigue—Metformin—type 2 diabetes mellitus	0.000717	0.000905	CcSEcCtD
Gallamine Triethiodide—Urticaria—Orlistat—type 2 diabetes mellitus	0.000717	0.000904	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000715	0.000902	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000713	0.0009	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000713	0.0009	CcSEcCtD
Gallamine Triethiodide—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000713	0.0009	CcSEcCtD
Gallamine Triethiodide—Angioedema—Ramipril—type 2 diabetes mellitus	0.000709	0.000894	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000704	0.000889	CcSEcCtD
Gallamine Triethiodide—Vomiting—Glyburide—type 2 diabetes mellitus	0.000704	0.000888	CcSEcCtD
Gallamine Triethiodide—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000703	0.000887	CcSEcCtD
Gallamine Triethiodide—Malaise—Ramipril—type 2 diabetes mellitus	0.0007	0.000883	CcSEcCtD
Gallamine Triethiodide—Rash—Glyburide—type 2 diabetes mellitus	0.000698	0.00088	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000697	0.00088	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000694	0.000876	CcSEcCtD
Gallamine Triethiodide—Headache—Glyburide—type 2 diabetes mellitus	0.000693	0.000875	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000685	0.000865	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.00068	0.000858	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000677	0.000855	CcSEcCtD
Gallamine Triethiodide—Cough—Ramipril—type 2 diabetes mellitus	0.000677	0.000854	CcSEcCtD
Gallamine Triethiodide—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000676	0.000854	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000673	0.000849	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000673	0.000849	CcSEcCtD
Gallamine Triethiodide—Pain—Irbesartan—type 2 diabetes mellitus	0.000671	0.000847	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000665	0.000839	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000663	0.000837	CcSEcCtD
Gallamine Triethiodide—Urticaria—Metformin—type 2 diabetes mellitus	0.00066	0.000833	CcSEcCtD
Gallamine Triethiodide—Chest pain—Ramipril—type 2 diabetes mellitus	0.00066	0.000833	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Ramipril—type 2 diabetes mellitus	0.00066	0.000833	CcSEcCtD
Gallamine Triethiodide—Nausea—Glyburide—type 2 diabetes mellitus	0.000657	0.000829	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000657	0.000829	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000656	0.000828	CcSEcCtD
Gallamine Triethiodide—Asthenia—Valsartan—type 2 diabetes mellitus	0.000655	0.000827	CcSEcCtD
Gallamine Triethiodide—Asthenia—Orlistat—type 2 diabetes mellitus	0.000647	0.000817	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000647	0.000816	CcSEcCtD
Gallamine Triethiodide—Pruritus—Valsartan—type 2 diabetes mellitus	0.000646	0.000815	CcSEcCtD
Gallamine Triethiodide—Confusional state—Ramipril—type 2 diabetes mellitus	0.000638	0.000806	CcSEcCtD
Gallamine Triethiodide—Pruritus—Orlistat—type 2 diabetes mellitus	0.000638	0.000805	CcSEcCtD
Gallamine Triethiodide—Fatigue—Losartan—type 2 diabetes mellitus	0.000637	0.000803	CcSEcCtD
Gallamine Triethiodide—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000632	0.000797	CcSEcCtD
Gallamine Triethiodide—Pain—Losartan—type 2 diabetes mellitus	0.000631	0.000797	CcSEcCtD
Gallamine Triethiodide—Rash—Gliclazide—type 2 diabetes mellitus	0.000627	0.000791	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000626	0.00079	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000625	0.000788	CcSEcCtD
Gallamine Triethiodide—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000623	0.000787	CcSEcCtD
Gallamine Triethiodide—Headache—Gliclazide—type 2 diabetes mellitus	0.000622	0.000786	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.00062	0.000783	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.00062	0.000783	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.00062	0.000782	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000618	0.00078	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000617	0.000779	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000615	0.000776	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000608	0.000768	CcSEcCtD
Gallamine Triethiodide—Asthenia—Metformin—type 2 diabetes mellitus	0.000596	0.000753	CcSEcCtD
Gallamine Triethiodide—Nausea—Gliclazide—type 2 diabetes mellitus	0.00059	0.000745	CcSEcCtD
Gallamine Triethiodide—Pruritus—Metformin—type 2 diabetes mellitus	0.000588	0.000742	CcSEcCtD
Gallamine Triethiodide—Urticaria—Losartan—type 2 diabetes mellitus	0.000587	0.00074	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000584	0.000737	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000584	0.000737	CcSEcCtD
Gallamine Triethiodide—Vomiting—Valsartan—type 2 diabetes mellitus	0.00058	0.000732	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000578	0.000729	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000577	0.000728	CcSEcCtD
Gallamine Triethiodide—Rash—Valsartan—type 2 diabetes mellitus	0.000576	0.000726	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000575	0.000726	CcSEcCtD
Gallamine Triethiodide—Vomiting—Orlistat—type 2 diabetes mellitus	0.000574	0.000724	CcSEcCtD
Gallamine Triethiodide—Headache—Valsartan—type 2 diabetes mellitus	0.000572	0.000722	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000569	0.000718	CcSEcCtD
Gallamine Triethiodide—Rash—Orlistat—type 2 diabetes mellitus	0.000569	0.000718	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000568	0.000717	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000568	0.000717	CcSEcCtD
Gallamine Triethiodide—Headache—Orlistat—type 2 diabetes mellitus	0.000565	0.000713	CcSEcCtD
Gallamine Triethiodide—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000563	0.00071	CcSEcCtD
Gallamine Triethiodide—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000555	0.0007	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000547	0.00069	CcSEcCtD
Gallamine Triethiodide—Fatigue—Ramipril—type 2 diabetes mellitus	0.000546	0.000689	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000544	0.000686	CcSEcCtD
Gallamine Triethiodide—Nausea—Valsartan—type 2 diabetes mellitus	0.000542	0.000684	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000537	0.000677	CcSEcCtD
Gallamine Triethiodide—Nausea—Orlistat—type 2 diabetes mellitus	0.000536	0.000676	CcSEcCtD
Gallamine Triethiodide—Asthenia—Losartan—type 2 diabetes mellitus	0.00053	0.000668	CcSEcCtD
Gallamine Triethiodide—Vomiting—Metformin—type 2 diabetes mellitus	0.000529	0.000667	CcSEcCtD
Gallamine Triethiodide—Rash—Metformin—type 2 diabetes mellitus	0.000524	0.000661	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Metformin—type 2 diabetes mellitus	0.000524	0.000661	CcSEcCtD
Gallamine Triethiodide—Pruritus—Losartan—type 2 diabetes mellitus	0.000522	0.000659	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000522	0.000658	CcSEcCtD
Gallamine Triethiodide—Headache—Metformin—type 2 diabetes mellitus	0.000521	0.000657	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000505	0.000638	CcSEcCtD
Gallamine Triethiodide—Urticaria—Ramipril—type 2 diabetes mellitus	0.000503	0.000635	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.0005	0.000632	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.0005	0.000632	CcSEcCtD
Gallamine Triethiodide—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000499	0.000629	CcSEcCtD
Gallamine Triethiodide—Rash—Irbesartan—type 2 diabetes mellitus	0.000495	0.000624	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000494	0.000624	CcSEcCtD
Gallamine Triethiodide—Nausea—Metformin—type 2 diabetes mellitus	0.000494	0.000623	CcSEcCtD
Gallamine Triethiodide—Headache—Irbesartan—type 2 diabetes mellitus	0.000491	0.00062	CcSEcCtD
Gallamine Triethiodide—Vomiting—Losartan—type 2 diabetes mellitus	0.000469	0.000592	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000466	0.000589	CcSEcCtD
Gallamine Triethiodide—Nausea—Irbesartan—type 2 diabetes mellitus	0.000466	0.000588	CcSEcCtD
Gallamine Triethiodide—Rash—Losartan—type 2 diabetes mellitus	0.000466	0.000587	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Losartan—type 2 diabetes mellitus	0.000465	0.000587	CcSEcCtD
Gallamine Triethiodide—Headache—Losartan—type 2 diabetes mellitus	0.000463	0.000584	CcSEcCtD
Gallamine Triethiodide—Asthenia—Ramipril—type 2 diabetes mellitus	0.000454	0.000573	CcSEcCtD
Gallamine Triethiodide—Pruritus—Ramipril—type 2 diabetes mellitus	0.000448	0.000565	CcSEcCtD
Gallamine Triethiodide—Nausea—Losartan—type 2 diabetes mellitus	0.000439	0.000553	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000433	0.000547	CcSEcCtD
Gallamine Triethiodide—Vomiting—Ramipril—type 2 diabetes mellitus	0.000403	0.000508	CcSEcCtD
Gallamine Triethiodide—Rash—Ramipril—type 2 diabetes mellitus	0.000399	0.000504	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000399	0.000503	CcSEcCtD
Gallamine Triethiodide—Headache—Ramipril—type 2 diabetes mellitus	0.000397	0.0005	CcSEcCtD
Gallamine Triethiodide—Nausea—Ramipril—type 2 diabetes mellitus	0.000376	0.000475	CcSEcCtD
Gallamine Triethiodide—ACHE—Metabolism—ABCC8—type 2 diabetes mellitus	0.000196	0.000946	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CBS—type 2 diabetes mellitus	0.000196	0.000946	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—VPS26A—type 2 diabetes mellitus	0.000194	0.000935	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CALCA—type 2 diabetes mellitus	0.000194	0.000934	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—type 2 diabetes mellitus	0.000191	0.000919	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—TCF7L2—type 2 diabetes mellitus	0.000189	0.000911	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—SLC5A2—type 2 diabetes mellitus	0.000189	0.00091	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—COX2—type 2 diabetes mellitus	0.000189	0.00091	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—MC4R—type 2 diabetes mellitus	0.000189	0.000909	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	0.000188	0.000905	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—GCG—type 2 diabetes mellitus	0.000186	0.000896	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NCOA6—type 2 diabetes mellitus	0.000186	0.000894	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	0.000185	0.000894	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	0.000183	0.000881	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—UCP3—type 2 diabetes mellitus	0.000182	0.000879	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—UCP2—type 2 diabetes mellitus	0.000182	0.000879	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—HSD11B1—type 2 diabetes mellitus	0.000182	0.000879	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GIP—type 2 diabetes mellitus	0.000182	0.000875	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—GCG—type 2 diabetes mellitus	0.00018	0.000865	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	0.000177	0.000852	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	0.000172	0.00083	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PCK1—type 2 diabetes mellitus	0.000172	0.000826	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—type 2 diabetes mellitus	0.000171	0.000821	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—ADRB3—type 2 diabetes mellitus	0.00017	0.000819	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	0.000169	0.000814	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	0.000168	0.000809	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—C3—type 2 diabetes mellitus	0.000167	0.000803	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	0.000165	0.000794	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	0.000165	0.000793	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CRHR1—type 2 diabetes mellitus	0.000164	0.000791	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	0.000161	0.000776	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—HK1—type 2 diabetes mellitus	0.000161	0.000774	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	0.00016	0.000773	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—GNB3—type 2 diabetes mellitus	0.00016	0.000772	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—type 2 diabetes mellitus	0.000158	0.000763	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—IGF2—type 2 diabetes mellitus	0.000157	0.000758	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	0.000157	0.000755	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—KCNJ11—type 2 diabetes mellitus	0.000155	0.000747	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GCKR—type 2 diabetes mellitus	0.000155	0.000747	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—LPA—type 2 diabetes mellitus	0.000155	0.000747	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—HSD3B2—type 2 diabetes mellitus	0.000155	0.000747	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—GNB3—type 2 diabetes mellitus	0.000155	0.000746	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—ADRB3—type 2 diabetes mellitus	0.000154	0.000744	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MTNR1A—type 2 diabetes mellitus	0.000153	0.000739	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—AVP—type 2 diabetes mellitus	0.000153	0.000736	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—MTNR1B—type 2 diabetes mellitus	0.00015	0.000724	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CRHR1—type 2 diabetes mellitus	0.000149	0.000719	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	0.000149	0.000719	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ALDOB—type 2 diabetes mellitus	0.000149	0.000717	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GLP1R—type 2 diabetes mellitus	0.000146	0.000705	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	0.000146	0.000704	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—EDN1—type 2 diabetes mellitus	0.000145	0.0007	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	0.000144	0.000696	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CCKAR—type 2 diabetes mellitus	0.000144	0.000694	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	0.000142	0.000682	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	0.00014	0.000674	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GLP1R—type 2 diabetes mellitus	0.000138	0.000666	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—MTNR1B—type 2 diabetes mellitus	0.000136	0.000657	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—EGFR—type 2 diabetes mellitus	0.000136	0.000657	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GLP1R—type 2 diabetes mellitus	0.000133	0.000641	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GCGR—type 2 diabetes mellitus	0.000132	0.000638	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCKAR—type 2 diabetes mellitus	0.000131	0.00063	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—type 2 diabetes mellitus	0.00013	0.000628	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CCR5—type 2 diabetes mellitus	0.00013	0.000626	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—IAPP—type 2 diabetes mellitus	0.00013	0.000625	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—SLC2A2—type 2 diabetes mellitus	0.000129	0.000622	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—C3—type 2 diabetes mellitus	0.000127	0.000611	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—TRPC6—type 2 diabetes mellitus	0.000127	0.00061	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—MTR—type 2 diabetes mellitus	0.000126	0.000609	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CPT1A—type 2 diabetes mellitus	0.000126	0.000609	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—MMP1—type 2 diabetes mellitus	0.000126	0.000609	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	0.000126	0.000607	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	0.000125	0.000603	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—AGT—type 2 diabetes mellitus	0.000125	0.000601	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NAMPT—type 2 diabetes mellitus	0.000124	0.000598	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	0.000123	0.000594	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—LIPC—type 2 diabetes mellitus	0.000123	0.000594	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GCK—type 2 diabetes mellitus	0.000123	0.000594	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—HBA1—type 2 diabetes mellitus	0.000123	0.000594	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP11A1—type 2 diabetes mellitus	0.000122	0.00059	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—LEP—type 2 diabetes mellitus	0.000122	0.000589	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GIPR—type 2 diabetes mellitus	0.000122	0.000587	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GRK5—type 2 diabetes mellitus	0.000122	0.000587	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	0.000121	0.000581	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—AGT—type 2 diabetes mellitus	0.000121	0.000581	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—SLC9A1—type 2 diabetes mellitus	0.00012	0.00058	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CETP—type 2 diabetes mellitus	0.000119	0.000573	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—IAPP—type 2 diabetes mellitus	0.000118	0.000567	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	0.000117	0.000564	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	0.000117	0.000562	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	0.000115	0.000554	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	0.000114	0.000551	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	0.000114	0.000549	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MC4R—type 2 diabetes mellitus	0.000111	0.000537	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	0.000111	0.000537	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	0.000111	0.000535	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	0.000111	0.000534	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PSMD6—type 2 diabetes mellitus	0.000111	0.000533	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—SNAP25—type 2 diabetes mellitus	0.000111	0.000533	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—SREBF1—type 2 diabetes mellitus	0.000111	0.000533	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	0.00011	0.000528	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	0.000109	0.000528	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CTGF—type 2 diabetes mellitus	0.000109	0.000523	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—HMGCR—type 2 diabetes mellitus	0.000108	0.000518	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GIP—type 2 diabetes mellitus	0.000107	0.000517	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	0.000106	0.000512	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	0.000106	0.000511	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ADRA2A—type 2 diabetes mellitus	0.000105	0.000507	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—INS—type 2 diabetes mellitus	0.000104	0.000503	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	0.000103	0.000498	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—CCL2—type 2 diabetes mellitus	0.000103	0.000495	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—LEPR—type 2 diabetes mellitus	0.000102	0.000491	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GCG—type 2 diabetes mellitus	0.000101	0.000489	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	0.000101	0.000488	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP2E1—type 2 diabetes mellitus	0.000101	0.000487	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	0.000101	0.000487	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—IGF1—type 2 diabetes mellitus	0.000101	0.000487	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GHRL—type 2 diabetes mellitus	0.000101	0.000485	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP1A2—type 2 diabetes mellitus	0.0001	0.000482	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—SLC2A1—type 2 diabetes mellitus	0.0001	0.000482	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	9.99e-05	0.000481	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CALCA—type 2 diabetes mellitus	9.95e-05	0.00048	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CCL2—type 2 diabetes mellitus	9.93e-05	0.000478	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP3A4—type 2 diabetes mellitus	9.75e-05	0.00047	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	9.74e-05	0.000469	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	9.7e-05	0.000467	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—SLC2A4—type 2 diabetes mellitus	9.58e-05	0.000462	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GCG—type 2 diabetes mellitus	9.58e-05	0.000462	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TLE4—type 2 diabetes mellitus	9.48e-05	0.000457	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GCG—type 2 diabetes mellitus	9.22e-05	0.000444	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ADRB3—type 2 diabetes mellitus	9.13e-05	0.00044	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	9.07e-05	0.000437	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CRHR1—type 2 diabetes mellitus	8.81e-05	0.000425	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	8.75e-05	0.000421	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—AVP—type 2 diabetes mellitus	8.63e-05	0.000416	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.26e-05	0.000398	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GNB3—type 2 diabetes mellitus	8.26e-05	0.000398	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—HMOX1—type 2 diabetes mellitus	8.22e-05	0.000396	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	8.21e-05	0.000395	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	8.13e-05	0.000392	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CAT—type 2 diabetes mellitus	8.11e-05	0.000391	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	8.06e-05	0.000388	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SPRY2—type 2 diabetes mellitus	8.06e-05	0.000388	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GNB3—type 2 diabetes mellitus	7.94e-05	0.000383	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—APOB—type 2 diabetes mellitus	7.88e-05	0.000379	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RBP4—type 2 diabetes mellitus	7.86e-05	0.000378	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GLP1R—type 2 diabetes mellitus	7.86e-05	0.000378	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—AVP—type 2 diabetes mellitus	7.84e-05	0.000378	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—MMP3—type 2 diabetes mellitus	7.84e-05	0.000378	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	7.8e-05	0.000376	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCKAR—type 2 diabetes mellitus	7.73e-05	0.000372	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GSTM1—type 2 diabetes mellitus	7.66e-05	0.000369	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—LPL—type 2 diabetes mellitus	7.52e-05	0.000362	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—EDN1—type 2 diabetes mellitus	7.45e-05	0.000359	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ADCY5—type 2 diabetes mellitus	7.36e-05	0.000355	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GPX1—type 2 diabetes mellitus	7.34e-05	0.000354	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	7.34e-05	0.000353	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—C3—type 2 diabetes mellitus	7.17e-05	0.000345	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CD36—type 2 diabetes mellitus	7.15e-05	0.000344	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	7.08e-05	0.000341	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PPP2CA—type 2 diabetes mellitus	7.06e-05	0.00034	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	7e-05	0.000337	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IAPP—type 2 diabetes mellitus	6.96e-05	0.000335	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—INSR—type 2 diabetes mellitus	6.92e-05	0.000333	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—AGT—type 2 diabetes mellitus	6.81e-05	0.000328	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	6.79e-05	0.000327	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	6.79e-05	0.000327	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—MTHFR—type 2 diabetes mellitus	6.77e-05	0.000326	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	6.75e-05	0.000325	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	6.66e-05	0.000321	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PPARA—type 2 diabetes mellitus	6.64e-05	0.00032	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—C3—type 2 diabetes mellitus	6.51e-05	0.000314	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	6.47e-05	0.000312	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—AGT—type 2 diabetes mellitus	6.43e-05	0.00031	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CALM1—type 2 diabetes mellitus	6.33e-05	0.000305	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—APOE—type 2 diabetes mellitus	6.3e-05	0.000304	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	6.3e-05	0.000303	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	6.28e-05	0.000303	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	6.28e-05	0.000303	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—APOA1—type 2 diabetes mellitus	6.23e-05	0.0003	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—AGT—type 2 diabetes mellitus	6.19e-05	0.000298	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	6.11e-05	0.000294	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	6.08e-05	0.000293	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CYBA—type 2 diabetes mellitus	6.08e-05	0.000293	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	5.98e-05	0.000288	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GHRL—type 2 diabetes mellitus	5.95e-05	0.000287	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PLAT—type 2 diabetes mellitus	5.95e-05	0.000287	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CALCA—type 2 diabetes mellitus	5.88e-05	0.000283	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	5.72e-05	0.000275	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	5.54e-05	0.000267	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	5.51e-05	0.000266	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PPARG—type 2 diabetes mellitus	5.49e-05	0.000265	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GCG—type 2 diabetes mellitus	5.44e-05	0.000262	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	5.44e-05	0.000262	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—INS—type 2 diabetes mellitus	5.39e-05	0.000259	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	5.36e-05	0.000258	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	5.34e-05	0.000257	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	5.1e-05	0.000245	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	5.01e-05	0.000241	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	5e-05	0.000241	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ALB—type 2 diabetes mellitus	4.94e-05	0.000238	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.74e-05	0.000228	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PIK3R1—type 2 diabetes mellitus	4.72e-05	0.000228	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NOS3—type 2 diabetes mellitus	4.72e-05	0.000228	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.69e-05	0.000226	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AVP—type 2 diabetes mellitus	4.63e-05	0.000223	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MMP3—type 2 diabetes mellitus	4.63e-05	0.000223	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IGF2—type 2 diabetes mellitus	4.61e-05	0.000222	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	4.59e-05	0.000221	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	4.54e-05	0.000219	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—APOB—type 2 diabetes mellitus	4.47e-05	0.000216	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	4.46e-05	0.000215	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—EDN1—type 2 diabetes mellitus	4.4e-05	0.000212	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PTGS2—type 2 diabetes mellitus	4.32e-05	0.000208	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—LPL—type 2 diabetes mellitus	4.27e-05	0.000206	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	4.18e-05	0.000201	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	4.01e-05	0.000193	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.94e-05	0.00019	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—C3—type 2 diabetes mellitus	3.85e-05	0.000185	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.67e-05	0.000177	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.66e-05	0.000176	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AGT—type 2 diabetes mellitus	3.66e-05	0.000176	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.59e-05	0.000173	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—LEP—type 2 diabetes mellitus	3.58e-05	0.000173	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—APOE—type 2 diabetes mellitus	3.58e-05	0.000173	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.54e-05	0.000171	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.38e-05	0.000163	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.19e-05	0.000154	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—INS—type 2 diabetes mellitus	3.06e-05	0.000147	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.01e-05	0.000145	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.96e-05	0.000143	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.96e-05	0.000142	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.94e-05	0.000142	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.81e-05	0.000135	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.68e-05	0.000129	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.68e-05	0.000129	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	2.53e-05	0.000122	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.3e-05	0.000111	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.28e-05	0.00011	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.26e-05	0.000109	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—AKT1—type 2 diabetes mellitus	2.17e-05	0.000105	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.15e-05	0.000104	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.13e-05	0.000103	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.09e-05	0.000101	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.98e-05	9.56e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.93e-05	9.31e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.77e-05	8.55e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.74e-05	8.38e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.34e-05	6.44e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.23e-05	5.94e-05	CbGpPWpGaD
